Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life.
Francesco MenzellaMatteo FontanaMarco ContoliPatrizia RuggieroCarla GaleoneSilvia CapobelliAnna SimonazziChiara CatellaniChiara ScelfoClaudia CastagnettiFrancesco LivrieriNicola FacciolongoPublished in: Journal of asthma and allergy (2022)
Our study, the longest clinical follow-up on patients treated with anti-IgE, confirms and amplifies the results of the studies carried out so far, as they are maintained over a very long interval of time without drops in efficacy without any type of side effect.
Keyphrases